The Liquid Biopsy and Tumor Progression in Breast Cancer
1 – 10 of 125
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Mammographic features at primary breast cancer diagnosis in relation to recurrence-free survival
(
- Contribution to journal › Article
-
Mark
Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750)
(
- Contribution to journal › Article
-
Mark
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit
(
- Contribution to journal › Article
-
Mark
Model of Health-Related Quality of Life in Breast Cancer Patients Using Cross-Sectional Data: The Role of Resilience
(
- Contribution to journal › Article
-
Mark
Axillary clearance and chemotherapy rates in ER+HER2− breast cancer : secondary analysis of the SENOMAC trial
(
- Contribution to journal › Article
-
Mark
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases
(
- Contribution to journal › Article
-
Mark
Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment : a post-hoc analysis of the randomised, phase 3 SENOMAC trial
(
- Contribution to journal › Article
-
Mark
Deep learning analysis of serial digital breast tomosynthesis images in a prospective cohort of breast cancer patients who received neoadjuvant chemotherapy
(
- Contribution to journal › Article
-
Mark
Preoperative prediction of nodal status using clinical data and artificial intelligence derived mammogram features enabling abstention of sentinel lymph node biopsy in breast cancer
(
- Contribution to journal › Article